Form 8-K - Current report:
SEC Accession No. 0001104659-25-019516
Filing Date
2025-03-03
Accepted
2025-03-03 08:18:56
Documents
30
Period of Report
2025-03-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258056d1_8k.htm   iXBRL 8-K 27943
2 EXHIBIT 99.1 tm258056d1_ex99-1.htm EX-99.1 45998
3 EXHIBIT 99.2 tm258056d1_ex99-2.htm EX-99.2 19218
7 GRAPHIC tm258056d1_ex99-1.jpg GRAPHIC 3020
8 GRAPHIC tm258056d1_ex99-2.jpg GRAPHIC 5584
9 GRAPHIC tm258056d1_ex99-2img001.jpg GRAPHIC 125357
10 GRAPHIC tm258056d1_ex99-2img002.jpg GRAPHIC 333248
11 GRAPHIC tm258056d1_ex99-2img003.jpg GRAPHIC 167778
12 GRAPHIC tm258056d1_ex99-2img004.jpg GRAPHIC 144162
13 GRAPHIC tm258056d1_ex99-2img005.jpg GRAPHIC 53624
14 GRAPHIC tm258056d1_ex99-2img006.jpg GRAPHIC 146331
15 GRAPHIC tm258056d1_ex99-2img007.jpg GRAPHIC 145940
16 GRAPHIC tm258056d1_ex99-2img008.jpg GRAPHIC 118781
17 GRAPHIC tm258056d1_ex99-2img009.jpg GRAPHIC 119971
18 GRAPHIC tm258056d1_ex99-2img010.jpg GRAPHIC 96813
19 GRAPHIC tm258056d1_ex99-2img011.jpg GRAPHIC 97397
20 GRAPHIC tm258056d1_ex99-2img012.jpg GRAPHIC 105532
21 GRAPHIC tm258056d1_ex99-2img013.jpg GRAPHIC 146856
  Complete submission text file 0001104659-25-019516.txt   2782598

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20250303.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20250303_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20250303_pre.xml EX-101.PRE 22373
32 EXTRACTED XBRL INSTANCE DOCUMENT tm258056d1_8k_htm.xml XML 3685
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 25693870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)